PubMed · 11798682
[Immune responses to recombinant expression plasmid encoding hepatitis C virus core antigen].
Abstract
OBJECTIVE: To study the feasibility of DNA immunization with recombinant expression plasmid containing hepatitis C virus (HCV) core gene against HCV infection. METHODS: The recombinant plasmid containing HCV C gene was constructed and expressed transiently by using lipofectamine in the mouse SP2/0 cells. After appraisal and purification, these plasmid and control DNA were directly injected intramuscularly into BALB/c mice, HCV C specific antibody in the sera was checked with ELISA. Proliferative responses of spleen cells from experimental and control mice were determined by (3)H thymidine incorporation and cytotoxicity T lymphocyte (CTL) activity was measured by standard 4-h (51)Cr release assays. RESULTS: All immunized mice developed anti-HCV core antibodies and this antibody was dose and immune number dependent. Lymphoproliferative responses for HCV core antigen were higher in immunized mice than in control mice (P < 0.05), stimulation indices (SI) were 2.42 - 6.10. CTLs might induce approximately 63.13% lysis of pcDNA HCV C transfected SP2/0 target cells. CONCLUSION: It is suggested that HCV C gene immunization is a promising method of vaccination against HCV infection.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Z Feng, Y Zhou, Z Jia, J Lian, J Li, W Li. 1999. [Immune responses to recombinant expression plasmid encoding hepatitis C virus core antigen].. https://pubmed.ncbi.nlm.nih.gov/11798682/
Cite the original work for its findings. Save a collection to share your selection of sources.